by admin | Jul 22, 2022 | News
Labiotech, a Berlin-based digital media company covering biotech, recently published an article highlighting Portuguese success stories, which include Exogenus Therapeutics and other “neighbors” headquartered in Biocant (Cantanhede), such as Immunethep and Biotrend....
by admin | Jun 13, 2022 | News
Joana Correia, Exogenus’s co-founder, CEO and CSO is an invited speaker at the IX BiotechHealth Annual Symposium, organized by i3S and taking place on June 28th 2022. Joana will be taking us on a trip from her days as an academic researcher to founding and...
by admin | May 25, 2022 | News
Today the final event of the InnoCore Challenge took place in Granada, Spain. Teams of MSc and PhD students were challenged to propose solutions for real problems faced by companies. Instead of focusing only on the scientific solutions, the teams also had to estimate...
by admin | Feb 24, 2022 | News
Exogenus Therapeutics is proud to announce a new research collaboration with Boehringer Ingelheim to explore the use of extracellular vesicles as therapeutic tools for regenerative medicine. This joint effort led by Boehringer Ingelheim’s Research Beyond Borders (RBB)...
by admin | Feb 23, 2022 | News
Exogenus Therapeutics is one of the five companies presenting projects in the Innocore Challenge. The initiative is part of the project “InnoCore – Core Technologies for Education and Innovation in Life Sciences”, funded by the Erasmus+ programme, and combines...
by admin | Nov 15, 2021 | News
Exogenus Therapeutics CEO, Joana Simões Correia, is again an invited speaker at the 3rd Exosome Based Therapeutic Development Summit, taking place virtually on November 17th and 18th, as part of a panel discussion about “Comparing Engineered & Naturally...
